Table 3

Global Advisory Committee for Vaccine Safety (GACVS) reports released during 1999–2019 that included review of data on autism

GACVS reportExposureOutcomeReport link
2002JuneDTPNeurodevelopmental delayhttps://www.who.int/vaccine_safety/committee/reports/wer7747.pdf?ua=1
2002DecemberMultipleAutismhttps://www.who.int/vaccine_safety/committee/reports/wer7804.pdf?ua=1
2004DecemberMultipleAutism, neurodevelopmental delayhttps://www.who.int/vaccine_safety/committee/topics/thiomersal/wer8001.pdf?ua=1
2012JuneAluminiumAutismhttps://www.who.int/vaccine_safety/committee/topics/thiomersal/wer8730.pdf?ua=1
2012JuneThiomersalMercury levels, autism, neurodevelopmental delay, special high-risk groups (eg, premature infants, immunocompromised infants)https://www.who.int/vaccine_safety/committee/topics/thiomersal/wer8730.pdf?ua=1
  • DTP, diphtheria, tetanus and pertussis vaccine.